Ellis, Matthew J <br/><br/>
Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.  [electronic resource] 

 -  Journal of the National Cancer Institute  Oct 2008 
 - 1380-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/djn309  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Analysis of Variance<br/>Anastrozole<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Aromatase Inhibitors--therapeutic use<br/>Biomarkers, Tumor--analysis<br/>Breast Neoplasms--chemistry<br/>Chemotherapy, Adjuvant<br/>Clinical Trials as Topic<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Ki-67 Antigen--analysis<br/>Letrozole<br/>Lymphatic Metastasis<br/>Middle Aged<br/>Neoadjuvant Therapy--methods<br/>Neoplasm Staging<br/>Nitriles--therapeutic use<br/>Postmenopause<br/>Predictive Value of Tests<br/>Prognosis<br/>Proportional Hazards Models<br/>Receptors, Estrogen--analysis<br/>Reproducibility of Results<br/>Risk Assessment<br/>Risk Factors<br/>Tamoxifen--therapeutic use<br/>Treatment Outcome<br/>Triazoles--therapeutic use